Coastal wetlands including salt marshes are among the most productive ecosystems on Earth. They are known for improving the quality of coastal water and provisioning coastal fisheries. However, this ecosystem is under potential threat due to urban coastal land reclamation, limited sediment supply, increased nutrient/eutrophication, and sea level rise. Therefore, restoration efforts to protect the degraded salt marsh habitat are considerably increasing worldwide. In this paper, we present an overview of salt marsh restoration techniques and success indicators. Published scientific literature in English language was collected by searching the most relevant keywords from popular search engines, namely, Google Scholar, Scopus, and Mendeley to get the information about salt marsh restoration techniques and success indicators. This study comprehensively reviewed data from 78 peer-reviewed papers. Results indicated that much of the salt marsh was restored through assisted abiotic strategies (e.g., recovery of tidal exchange, managed realignment, and sediment level amendment). A total of 214 indicators were found, spanning over six major ecological attributes such as structural diversity, ecosystem functions, physical conditions, species composition, external exchange, and absence of threat. Author keywords analysis revealed several hotspots for recent research (e.g., 16 s rRNA, fungi, microbial communities, carbon accumulation, and blue carbon). This paper proposes a model for restoring degraded salt marsh, as well as tracking their success. The information presented here will assist the marine ecosystem restoration practitioners in getting a comprehensive understanding of salt marsh restoration success evaluation.
Human viral oncogenesis is a complex phenomenon and a major contributor to the global cancer burden. Several recent findings revealed cellular and molecular pathways that promote the development and initiation of malignancy when viruses cause an infection. Even, antiviral treatment has become an approach to eliminate the viral infections and prevent the activation of oncogenesis. Therefore, for a better understanding, the molecular pathogenesis of various oncogenic viruses like, hepatitis virus, human immunodeficiency viral (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), and Epstein-Barr virus (EBV), could be explored, especially, to expand many potent antivirals that may escalate the apoptosis of infected malignant cells while sparing normal and healthy ones. Moreover, contemporary therapies, such as engineered antibodies antiviral agents targeting signaling pathways and cell biomarkers, could inhibit viral oncogenesis. This review elaborates the recent advancements in both natural and synthetic antivirals to control viral oncogenesis. The study also highlights the challenges and future perspectives of using antivirals in viral oncogenesis.